Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SHIN NIPPON BIOMEDICAL, The Current Fiscal Year Ordinary Profit Revised Upward by 10%
2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 【J-GAAP】
Earnings ReportSHIN NIPPON BIOMEDICAL LABORATORIES, LTD. <2395> [TSE Prime] announced its financial results at noon (11:30) on February 5th. The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 15.3% from the same period last year to 4.13 billion yen.
However, the full-year consolidated ordinary profit has been revised upward 10.4%, from the previous forecast of 5.34 billion yen to 5.9 billion yen (compared to 7.01 billion yen in the previous period), and the declining rate is expected to decrease from 23.8% to 15.9%.
Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) is expected to increase 15.8%, from the previous forecast of 3.51 billion yen to 4.07 billion yen (compared to 3.25 billion yen in the same period of the previous year), increasing the growth rate from 7.9% to 24.9%.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.0 times that of the same period last year, reaching 2.3 billion yen. The operating profit margin drastically improved from 3.0% in the same period last year to 18.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 16,371 | 3,783 | 6,880 | 4,351 | 104.5 | 74.8 | Jan 31, 2023 | J-GAAP |
Apr - Dec, 2023 | 17,984 | 2,535 | 4,884 | 3,794 | 91.1 | 69.6 | Feb 2, 2024 | J-GAAP |
Apr - Dec, 2024 | 22,235 | 1,893 | 4,138 | 3,205 | 77.0 | 70.1 | Feb 5, 2025 | J-GAAP |
YoY | +23.6% | -25.3% | -15.3% | -15.5% | -15.5% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 17,327 | 2,270 | 3,516 | 2,589 | 62.2 | 30 | Nov 6, 2024 | J-GAAP |
Oct - Mar, 2024 New | 19,492 | 2,820 | 4,071 | 3,069 | 73.7 | 30 | Feb 5, 2025 | J-GAAP |
Revision Rate | +12.5% | +24.2% | +15.8% | +18.5% | +18.5% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 29,835 | 2,350 | 5,345 | 3,920 | 94.2 | 50 | May 8, 2024 | J-GAAP |
Mar, 2025 New | 32,000 | 2,900 | 5,900 | 4,400 | 105.7 | 50 | Feb 5, 2025 | J-GAAP |
Revision Rate | +7.3% | +23.4% | +10.4% | +12.2% | +12.2% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 14,566 | 1,813 | 3,259 | 2,565 | 61.6 | 30 | May 8, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 19,492 | 2,820 | 4,071 | 3,069 | 73.7 | 30 | Feb 5, 2025 | J-GAAP |
YoY | +33.8% | +55.5% | +24.9% | +19.6% | +19.7% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 25,090 | 5,245 | 9,194 | 6,060 | 145.6 | 50 | May 8, 2023 | J-GAAP |
Mar, 2024 | 26,450 | 4,162 | 7,015 | 5,531 | 132.9 | 50 | May 8, 2024 | J-GAAP |
Mar, 2025 Guidance | 32,000 | 2,900 | 5,900 | 4,400 | 105.7 | 50 | Feb 5, 2025 | J-GAAP |
YoY | +21.0% | -30.3% | -15.9% | -20.4% | -20.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 6,100 | 186 | 1,128 | 828 | 19.9 | 3.0 | Feb 2, 2024 | J-GAAP |
Jan - Mar, 2024 | 8,466 | 1,627 | 2,131 | 1,737 | 41.7 | 19.2 | May 8, 2024 | J-GAAP |
Apr - Jun, 2024 | 5,549 | -145 | 342 | 122 | 2.9 | -2.6 | Aug 6, 2024 | J-GAAP |
Jul - Sep, 2024 | 6,959 | 225 | 1,487 | 1,209 | 29.0 | 3.2 | Nov 6, 2024 | J-GAAP |
Oct - Dec, 2024 | 9,727 | 1,813 | 2,309 | 1,874 | 45.0 | 18.6 | Feb 5, 2025 | J-GAAP |
YoY | +59.5% | +874.7% | +104.7% | +126.3% | +126.3% |
Related Articles
ENSHU TRUCK, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 29%, Oct-Dec Ordinary Profit Increases by 45%
Shinsho, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%
ASAHI KASEI, The Current Fiscal Year Ordinary Profit Revised Downward by 2%
Toho Bank, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 20%
Nippon Yusen Kabushiki Kaisha, The Current Fiscal Year Ordinary Profit Revised Upward by 17%, Dividend Revised Upward by 50 yen
Marubeni, The Current Fiscal Year Net Income Revised Upward by 4%, Dividend Revised Upward by 5 yen
Nikkei 225 open on the 5th = 180 yen higher, 38,979 yen
CREATE, The Current Fiscal Year Ordinary Profit Revised Downward by 23%, Dividend Revised down by 8 yen
SATO SHOJI, The Current Fiscal Year Ordinary Profit Revised Upward by 1%, Dividend Revised Upward by 5 yen
SANKYO, The Current Fiscal Year Ordinary Profit Revised Upward by 16%, Dividend Revised Upward by 20 yen